JPRN-UMIN000019466已完成2 期
Phase II clinical trial on systemic oxaliplatin chemotherapy plus molecular target therapy combined with hepatic arterial infusion (HAI) therapy for colorectal liver metastases - Systemic chemotherapy combined with HAI therapy for CRLM
Department of Gastroenterological Surgery, Tokai University School of Medicine0 个研究点目标入组 47 人开始时间: 2015年10月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 47
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Intestinal pneumonia presenting clinical signs. 2. Severe infectious diseases. 3. Severely complicated diseases including heart failure, liver malfunction, renal failure and uncontrolled diabetes. 4. Anorexia 5. Women who are pregnant, lactate or have a probability of pregnancy. 6. History of allergy against fluorouracil, leucovorin, oxaliplatin and/or cetuximab. 7. Patients whom the researcher judged as ineligible.
研究者
相似试验
招募中
2 期
A phase II trial of oxaliplatin, capecitabine, irinotecan (XELOXIRI) and bevacizumab as first-line therapy for patients with metastatic colorectal cancermetastatic colorectal cancerJPRN-UMIN000039783Sapporo Medical University School of Medicine47
未知
Unknown
A phase 1/2 trial of Oxaliplatin(L-OHP) + S-1 in patients with previously untreated advanced colorectal cancerColorectal cancerJPRN-jRCT2080220116Yakult Honsha Co.,Ltd.
已完成
1 期
Phase I/II study of the combination of Oxaliplatin and S-1 in patients with advanced/recurrent colorectal cancerunresectable advanced/recurrent colorectal cancerJPRN-C000000443Outpatient Oncology Unit Kyoto University Hospital42
已完成
3 期
A randomized phase III study of oxaliplatin based chemotherapy versus combination chemotherapy of TS-1,irinotecan and bevacizumab as first line therapy for unresectable or recurrent colorectal cancerJPRN-UMIN000007834The Tokyo Cooperative Oncology Group450
进行中（未招募）
不适用
Phase II trial of second line therapy with Oxaliplatin and Pemetrexed in patients with advanced pancreatic cancer - Pemetrexed_OxaliplatinoAdvanced pancreatic cancer patientsMedDRA version: 14.1Level: PTClassification code 10059326Term: Pancreatic carcinoma stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2006-001272-21-ITAZIENDA OSPEDALIERO-UNIVERSITARIA S. MARIA DELLA MISERICORDIA DI UDINE